November 23, 2020

AstraZeneca and University of Oxford media briefing

Journalists from around the world were invited to join a media briefing webinar on the positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil.

Speakers included:

Prof Andrew Pollard, Director of the Oxford Vaccine Group, Department of Paediatrics, University of Oxford

Prof Sarah Gilbert, Saïd Professorship of Vaccinology, Jenner Institute, Nuffield Department of Medicine, University of Oxford

Prof Louise Richardson, Vice Chancellor of the University of Oxford

Pascal Soriot, Chief Executive Officer, AstraZeneca

Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca

Pam Cheng, Executive Vice President, Operations and Information Technology, AstraZeneca

This Briefing was accompanied by and SMC Roundup of Comments.